(11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one

C24H30N6O4S — CID 163243868

IUPAC(11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
SMILESCC(C)C[C@@H]1COc2cc(-c3ccnn3CC(C)C)nc(n2)NS(=O)(=O)c2cccc(c2)C(=O)N1
InChIInChI=1S/C24H30N6O4S/c1-15(2)10-18-14-34-22-12-20(21-8-9-25-30(21)13-16(3)4)27-24(28-22)29-35(32,33)19-7-5-6-17(11-19)23(31)26-18/h5-9,11-12,15-16,18H,10,13-14H2,1-4H3,(H,26,31)(H,27,28,29)/t18-/m1/s1
InChIKeyCEQNTPROLDXJOP-GOSISDBHSA-N
MW498.61 g/mol
LogP3.33
Rot. Bonds5

About (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one

(11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one (PubChem CID 163243868) has the molecular formula C24H30N6O4S and a molecular weight of 498.61 g/mol. Its IUPAC name is (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one.

Molecular Properties

Compound Name(11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
PubChem CID163243868
Molecular FormulaC24H30N6O4S
Molecular Weight498.61 g/mol
Exact Mass498.20
IUPAC Name(11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
SMILESCC(C)C[C@@H]1COc2cc(-c3ccnn3CC(C)C)nc(n2)NS(=O)(=O)c2cccc(c2)C(=O)N1
InChIInChI=1S/C24H30N6O4S/c1-15(2)10-18-14-34-22-12-20(21-8-9-25-30(21)13-16(3)4)27-24(28-22)29-35(32,33)19-7-5-6-17(11-19)23(31)26-18/h5-9,11-12,15-16,18H,10,13-14H2,1-4H3,(H,26,31)(H,27,28,29)/t18-/m1/s1
InChIKeyCEQNTPROLDXJOP-GOSISDBHSA-N
XLogP3.33
TPSA128.10 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds5
Heavy Atoms35
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500498.61
LogP ≤ 53.33
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(11R)-6-(2-benzylpyrazol-3-yl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411547
(11R)-11-(2-methylpropyl)-2,2-dioxo-6-(1H-pyrazol-4-yl)-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411532
(11R)-6-(cyclopenten-1-yl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411354
(11R)-6-(2-cyclopropylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 163243595
(11R)-6-(2-methoxyphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411436
(11R)-6-(3,4-dihydro-2H-pyran-6-yl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411399
(11R)-6-[2-(hydroxymethyl)-6-methylphenyl]-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170403169
(11R)-6-(2,6-dimethylcyclohexen-1-yl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 163243935
(11R)-6-(4,4-dimethylcyclohexen-1-yl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411367
(11R)-6-(5-methoxy-2-methylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411175
(11R)-6-(2,6-dimethylphenyl)-11-(2-methylpropyl)-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,16,19-pentazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170412286
(11R)-11-(2-methylpropyl)-2,2-dioxo-6-[3-(trifluoromethyl)pyrazol-1-yl]-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one
CID 170411243

Frequently Asked Questions

What is the IUPAC name of (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The IUPAC name of (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one (CID 163243868) is (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one.
What is the SMILES notation for (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The canonical SMILES for (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one is CC(C)C[C@@H]1COc2cc(-c3ccnn3CC(C)C)nc(n2)NS(=O)(=O)c2cccc(c2)C(=O)N1.
What is the InChIKey of (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
The InChIKey is CEQNTPROLDXJOP-GOSISDBHSA-N. The full InChI is InChI=1S/C24H30N6O4S/c1-15(2)10-18-14-34-22-12-20(21-8-9-25-30(21)13-16(3)4)27-24(28-22)29-35(32,33)19-7-5-6-17(11-19)23(31)26-18/h5-9,11-12,15-16,18H,10,13-14H2,1-4H3,(H,26,31)(H,27,28,29)/t18-/m1/s1.
What are the key properties of (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one?
(11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one has a molecular weight of 498.61 g/mol, XLogP of 3.33, 5 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (11R)-11-(2-methylpropyl)-6-[2-(2-methylpropyl)pyrazol-3-yl]-2,2-dioxo-9-oxa-2λ6-thia-3,5,12,19-tetrazatricyclo[12.3.1.14,8]nonadeca-1(17),4,6,8(19),14(18),15-hexaen-13-one is sourced from PubChem (CID 163243868), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).